Publication: Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancement
Issued Date
2019-01-28
Resource Type
ISSN
20403372
20403364
20403364
Other identifier(s)
2-s2.0-85060369110
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nanoscale. Vol.11, No.4 (2019), 2079-2088
Suggested Citation
Ioannis G. Theodorou, Pakatip Ruenraroengsak, Daniel A. Gonzalez-Carter, Qianfan Jiang, Ernesto Yagüe, Eric O. Aboagye, R. Charles Coombes, Alexandra E. Porter, Mary P. Ryan, Fang Xie Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancement. Nanoscale. Vol.11, No.4 (2019), 2079-2088. doi:10.1039/c8nr09409h Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51180
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancement
Abstract
© The Royal Society of Chemistry. Sensitive detection of disease biomarkers expressed by human cells is critical to the development of novel diagnostic and therapeutic methods. Here we report that plasmonic arrays based on gold nanostar (AuNS) monolayers enable up to 19-fold fluorescence enhancement for cellular imaging in the near-infrared (NIR) biological window, allowing the application of low quantum yield fluorophores for sensitive cellular imaging. The high fluorescence enhancement together with low autofluorescence interference in this wavelength range enable higher signal-to-noise ratio compared to other diagnostic modalities. Using AuNSs of different geometries and therefore controllable electric field enhancement, cellular imaging with tunable enhancement factors is achieved, which may be useful for the development of multicolour and multiplexed platforms for a panel of biomarkers, allowing to distinguish different subcell populations at the single cell level. Finally, the uptake of AuNSs within HeLa cells and their high biocompatibility, pave the way for novel high-performance in vitro and in vivo diagnostic platforms.